Advertisement
Screener

Allogene Therapeutics, Inc. (ALLO) Market Cap

Allogene Therapeutics, Inc. (ALLO) Market Cap

  • 2026-09-03: Market Cap $682.34M.
  • 2026-08-10: Market Cap $725.53M.
  • 2026-06-30: Market Cap $718.32M.
  • 2026-05-11: Market Cap $786.95M.

Historical market capitalization from contemporaneous retained split-adjusted close and filed split-adjusted shares outstanding.

Available history
2018-11-15 to 2026-09-03
Data captured

Historical Market Cap

DateMarket Cap
2026-09-03$682.34M
2026-08-10$725.53M
2026-06-30$718.32M
2026-05-11$786.95M
2026-03-31$597.35M
2026-03-10$660.64M
2025-12-31$314.3M
2025-11-04$249.45M
2025-09-30$276.72M
2025-08-11$228.54M
2025-06-30$248.75M
2025-05-09$253.73M
2025-03-31$319.15M
2025-03-07$473.64M
2024-12-31$452.01M
2024-11-01$570.31M
2024-09-30$586.6M
2024-08-02$537.42M
2024-06-30$487.09M
2024-05-09$488.64M
2024-03-31$761.92M
2024-03-12$828.55M
2023-12-31$541.34M
2023-10-31$474.54M
2023-09-30$533.12M
2023-07-31$831.43M
2023-06-30$830.65M
2023-05-01$806.5M
2023-03-31$719.96M
2023-02-24$894.44M
2022-12-31$908.52M
2022-10-31$1.49B
2022-09-30$1.56B
2022-08-05$2.22B
2022-06-30$1.64B
2022-05-02$1.31B
2022-03-31$1.31B
2022-02-21$1.33B
2021-12-31$2.13B
2021-11-02$2.79B
2021-09-30$3.66B
2021-08-02$3.21B
2021-06-30$3.71B
2021-05-03$4.34B
2021-03-31$4.99B
2021-02-22$4.82B
2020-12-31$3.55B
2020-11-02$4.66B
2020-09-30$5.27B
2020-08-03$5.23B
2020-06-30$5.96B
2020-05-04$3.97B
2020-03-31$2.44B
2020-02-24$3.12B
2019-12-31$3.23B
2019-11-01$3.53B
2019-09-30$3.32B
2019-08-02$3.6B
2019-06-30$3.27B
2019-05-03$3.67B
2019-03-31$3.51B
2019-03-04$3.88B
2018-12-31$3.27B
2018-11-15$3.27B

Similar stocks

Stock NameCountryMarket CapPE Ratio
Prime Medicine, Inc. (PRME)United States$0.557B-3.54
Aura Biosciences, Inc. (AURA)United States$0.639B-5.61
Autolus Therapeutics plc (AUTL)$0.506B-1.52
Entera Bio Ltd. (ENTX)$0.485B
REGENXBIO Inc. (RGNX)United States$0.477B-3.30
Tectonic Therapeutic, Inc. (TECX)United States$0.469B-7.68
Eikon Therapeutics, Inc. (EIKN)United States$0.446B
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
4D Molecular Therapeutics, Inc. (FDMT)United States$0.733B-4.10